For those of you who didn’t get the chance to participate at the 2011 European Multidisciplinary Cancer Congress, here is a series of short video introductions.
ECCO President Prof Michael Baumann discusses the European Multidisciplinary Cancer Congress 2011 in Stockholm
The importance of a multidisciplinary approach to the development of cancer treatments is outlined by Michael Baumann. President of ECCO, Professor Baumann speaks about the concrete outcomes of the 2011 European Multidisciplinary Cancer Congress in Stockholm. Among the priorities are personalised medicine, taking the patient’s perspective, promoting oncopolicy and advancing the importance of a multidisciplinary approach to cancer research, education, treatment and care, as well as clinical trials.
Prof Michael Baumann, President of the European CanCer Organisation, Brussels, Belgium
Opportunities for young oncologists attending the 2011 European Multidisciplinary Cancer Congress
Dr Katherina Farr explains how the European Multidisciplinary Cancer Congress offers young oncologists the opportunity to learn about the latest research results. It is important in this era of mutidisciplinary oncology that all aspects of cancer care are closely linked and have a good understanding of the major clinical advances in various treatment fields. The congress also provides networking opportunities valuable to a young oncologist’s career development.
Dr Katherina Farr, Aarhus University Hospital, Denmark
Benefits of the European Multidisciplinary Cancer Congress for young oncologists
Dr Duveken Fontein discusses the value of the Stockholm Congress to young oncologists. This meeting played an important role for inspiring young clinicians and offered a chance to meet and interact with leaders in the field from all disciplines. In addition, the ECCO-ESMO-ESTRO meeting provided an opportunity for younger researchers to present their work, both orally and in poster sessions.
Dr Duveken Fontein, Leiden University Medical Center, The Netherlands
Key benefits of the European Multidisciplinary Cancer Congress
Dr Karin Tamas outlines some of the key benefits to clinicians attending the Stockholm Congress. The meeting offered the opportunity to learn about advances being achieved in many different fields thanks to the emphasis on multidisciplinary approaches to cancer therapy. Oncologists attending the meeting had the chance to interact with colleagues from a range of geographical and clinical backgrounds, to learn from them and to build valuable networking links.
Dr Karin Tamas – Szent Laszlo Teaching Hospital, Budapest, Hungary
PRINT THIS PAGE
Page last modified: